GYRE,Gyre Therapeutics, Inc. | Healthcare

Healthcare

GYRE

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Gyre Therapeutics, Inc.GYRE

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

695.54M

Revenue (ttm)

105.76M

Net Income (ttm)

12.09M

Shares Out

93.61M

EPS (ttm)

0.05

PE Ratio

151.63

Forward PE

60.75

Dividend

n/a

Ex-Dividend Date

n/a

Volume

43,495

Open

7.58

Previous Close

7.29

Day's Range

7.03 - 7.43

52-Week Range

6.11 - 19.00

Beta

n/a

Analysts

n/a

Price Target

n/a

Earnings Date

May 19, 2025

Description >

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally.

It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease.

The company was founded in 2002 and is headquartered in South San Francisco, California.

Latest News >

SkyWater-Fabricated Qubits Help D-Wave Achieve 'Computational Supremacy' in Quantum Simulation

Mar 12, 2025

07:07 AM EDT, 03/12/2025 (MT Newswires) -- D-Wave Quantum's ( QBTS ) Advantage2 prototype, fabricated by SkyWater Technology ( SKYT ) , was used to achieve computational supremacy in quantum simulation, the companies said Wednesday. D-Wave's annealing quantum computer outperformed one of most powerful classical supercomputers in the world in solving complex magnetic materials simulation problems with relevance to materials...

RBC Previews Wednesday's Bank of Canada Policy Meeting

Mar 12, 2025

07:02 AM EDT, 03/12/2025 (MT Newswires) -- The Bank of Canada meeting of Wednesday will need to weigh current/past fundamentals against risk factors of unknown magnitude, said RBC. Canada's central bank is slated to release the policy statement at 9:45 a.m. ET on Wednesday. Unlike 2024 and early 2025 when RBC had high conviction in the path and sequencing of...

Lazard Posts Decrease in Assets Under Management for February

Mar 12, 2025

07:03 AM EDT, 03/12/2025 (MT Newswires) -- Lazard ( LAZ ) reported preliminary assets under management Wednesday of $232.88 billion as of Feb. 28, down from $233.02 billion a month earlier. The asset management firm reported a market appreciation of $100 million, foreign exchange appreciation of $500 million, and net outflows of $800 million for February. ...

Fortuna Releases Updated Mineral Reserves, Mineral Resources at End-2024

Mar 12, 2025

07:09 AM EDT, 03/12/2025 (MT Newswires) -- Fortuna Mining ( FSM ) on Wednesday provided updated mineral reserve and mineral resource estimates as of Dec. 31 for its four operating mines in West Africa and the Americas as well as the Arizaro project at the Lindero Mine in Argentina, the Diamba Sud gold project in Senegal and the San Jose...